Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the pembrolizumab and liver-directed or radionuclide therapy study, including its study details and results information, rather than a 403 error.
    Difference
    61%
    Check dated 2026-11-08T14:12:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:38:35.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with both terms appearing during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:28:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:00.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:53:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with accompanying header text, and the visible study content appears unavailable while the site header/footer remain; this indicates the study record is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-20T19:55:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.